Home > Healthcare > Pharmaceuticals > Finished Drug Form > Abortion Drugs Market

Abortion Drugs Market Size

Report ID: GMI8059
Published Date: Feb 2024
Report Format: PDF

Download Free Sample

Abortion Drugs Market Size

Abortion Drugs Market was valued at around USD 24.4 billion in 2023 and is estimated to grow at a CAGR of 8.2% between 2024 and 2032. Abortion drugs, also known as medication abortion or medical abortion, refer to a non-surgical method of terminating a pregnancy using pharmaceutical drug delivery. This approach involves the use of medication rather than a surgical procedure to induce abortion.

To get key market trends

Download Free Sample

As per U.S. Department of Health & Human Services, in 2020, the adolescent birth rate stood at 15.4 (births per 1,000 females aged 15-19), marking an 8% decrease from 2019. With 158,043 births among females in this age bracket, these accounted for less than five percent of all births in 2020.

Furthermore, as awareness about reproductive health and abortion options expand, teenagers may increasingly seek information about non-surgical methods, leading to a higher demand for abortion pills. Improved accessibility to healthcare services and information may contribute to this trend. Thus, the abovementioned factors are anticipated to augment business expansion.

Abortion Drugs Market Report Attributes
Report Attribute	Details
Base Year:	2023
Abortion Drugs Market Size in 2023:	USD 24.4 Billion
Forecast Period:	2024 - 2032
Forecast Period 2024 - 2032 CAGR:	8.2%
2032 Value Projection:	USD 49.3 Billion
Historical Data for:	2018 - 2023
No. of Pages:	95
Tables, Charts & Figures:	155
Segments covered:	Drug Class, Distribution Channel, and Region
Growth Drivers:	Rising incidence of unplanned pregnancies Increasing focus on womens reproductive rights Advancements in medical technology Increasing awareness and education
Pitfalls & Challenges:	Social and cultural stigma High cost and side-effects associated with certain drugs Stringent regulatory environment

Learn more about the key segments shaping this market

Download Free Sample

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global market size for abortion drugs was valued at around USD 24.4 billion in 2023 and is estimated to reach USD 49.3 billion by 2032, at a CAGR of 8.2%, driven by improving awareness about reproductive health and abortion options.

The mifepristone drug class segment is poised for significant growth at 8.6% through 2032, owing to its efficacy and non-invasive nature.

North America abortion drugs industry accounted for USD 11.1 billion in 2023 and is predicted to witness substantial growth over 2024 and 2032, driven by a favorable legal and regulatory environment.

Cipla Limited, Endo International plc, Exelgyn, Gedeon Richter plc, Jubilant Life Sciences, Lupin Limited, Mylan N.V., Pfizer Inc., Sun Pharmaceutical Industries, Torrent Pharmaceuticals Ltd., Zydus Lifesciences Limited are some of the major industry contenders.